Peripheral Nervous System Neoplasms: Clinical Trials

108 trials for Peripheral Nervous System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

61 completed, 16 recruiting, 13 terminated, 8 active not recruiting. 108 Phase 1, 29 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1108Completed 61, Recruiting 16, Terminated 13, Active not recruiting 8, Unknown 3, Enrolling by invitation 2, Not yet recruiting 2, Withdrawn 2, Suspended 1
Phase 229Completed 8, Recruiting 7, Terminated 6, Active not recruiting 4, Not yet recruiting 2, Enrolling by invitation 1, Unknown 1

Follow Peripheral Nervous System Neoplasms: new trials by email Literature Review of Peripheral Nervous System Neoplasms trials Research Report on Peripheral Nervous System Neoplasms

Trials (filtered) newest first · largest first

All 108 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST
Phase 1 / Phase 2RecruitingAnkit Mangla, MD172026-08-012026-08-11
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2
Phase 1 / Phase 2Not yet recruitingBeijing Tiantan Hospital302026-07-312026-07-16
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
[89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor
Phase 1RecruitingRobert Flavell, MD, PhD402026-06-152026-10-01
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Cabozantinib Oral Tablet, Selumetinib Oral Capsule - Neurofibromatosis 1, Plexiform Neurofibroma
Phase 1RecruitingGirish Dhall, MD302026-06-092026-10-02
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1)
Phase 1 / Phase 2RecruitingAeRang Kim452026-06-012026-07-27
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma
Phase 1 / Phase 2RecruitingUniversity of Florida272026-02-112026-06-30
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Imlygic - NF1, Neurofibromatosis
Phase 1RecruitingJohns Hopkins University102026-02-012026-05-08
A Study of DEG6498 in Participants With Solid Tumors
DEG6498 - Malignant Neoplasms
Phase 1RecruitingDegron Therapeutics Co.1002025-11-132026-06-30
Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
Luvometinib Tablets - Neurofibromatosis 1, Plexiform Neurofibroma
Phase 1 / Phase 2Not yet recruitingShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.652025-06-122025-06-17
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
PAS-004 Tablets, PAS-004 Capsule - NF1 Mutation, Neurofibroma Plexiform
Phase 1RecruitingPasithea Therapeutics Corp.562025-05-302026-10-28
Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
BNCT, [18F]FBPA - Thoracic Solid Malignant Tumor
Phase 1 / Phase 2Enrolling by invitationStella Pharma Corporation302025-04-102025-11-19
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
Kybella - Neurofibromas, Cutaneous, Neurofibromatosis 1
Phase 1Enrolling by invitationMassachusetts General Hospital152025-04-082026-04-22
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
AAVAnc80-antiVEGF via Akouos Delivery Device - Vestibular Schwannoma
Phase 1 / Phase 2RecruitingEli Lilly and Company272025-01-172026-11-04
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital1392024-03-272026-08-03
A Study of Avutometinib for People With Solid Tumor Cancers
Avutometinib - Refractory Cancer, CNS Tumors
Phase 1CompletedMemorial Sloan Kettering Cancer Center32023-10-202026-11-04
SPEARHEAD-3 Pediatric Study
Afamitresgene autoleucel - Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST)
Phase 1 / Phase 2RecruitingUSWM CT, LLC202023-09-012026-08-11
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
TNG462, Pembrolizumab - Locally Advanced Solid Tumor
Phase 1 / Phase 2RecruitingTango Therapeutics, Inc.2252023-05-262026-09-08
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital482022-07-062026-05-19
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
MRTX1719 - Mesothelioma, Non Small Cell Lung Cancer
Phase 1RecruitingBristol-Myers Squibb3362022-06-092026-09-02
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
TNG908 - Locally Advanced Solid Tumor
Phase 1 / Phase 2TerminatedTango Therapeutics, Inc.1102022-03-232026-04-15

Showing 20 of 108. Sign in to see all of them.

Narrower conditions

Optic Nerve Glioma (48)  ·  Astrocytoma (46)  ·  Medulloblastoma (43)  ·  Familial ependymoma (40)  ·  Neurofibrosarcoma (35)  ·  Sarcoma (35)  ·  Oligodendroglioma (33)  ·  Choroid Plexus Neoplasms (32)  ·  Central Nervous System Neoplasms (31)  ·  Neuroblastoma (24)  ·  Osteosarcoma (20)  ·  Rhabdoid Tumor (18)  ·  Wilms Tumor (18)  ·  Sarcoma, Synovial (16)  ·  Neuroectodermal Tumors, Primitive, Peripheral (15)

Broader conditions

Nervous System Diseases (108)  ·  Nervous System Neoplasms (108)  ·  Neoplasms by Histologic Type (107)  ·  Neoplasms, Nerve Tissue (107)  ·  Neoplasms (102)  ·  Neoplasms by Site (68)  ·  Neuroectodermal Tumors (66)  ·  Neoplasms, Glandular and Epithelial (64)  ·  Neoplasms, Germ Cell and Embryonal (62)  ·  Neoplasms, Neuroepithelial (59)  ·  Nerve Sheath Neoplasms (58)  ·  Neuromuscular Diseases (57)  ·  Peripheral Nervous System Diseases (57)  ·  Cranial Nerve Diseases (54)

Interventions

Filgrastim (10)  ·  Temozolomide (9)  ·  Carboplatin (8)  ·  AZD 6244 (5)  ·  Ifosfamide (5)  ·  Etoposide (4)  ·  Granulocyte Colony-Stimulating Factor (4)  ·  Radiotherapy (4)  ·  pazopanib (4)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (3)  ·  Busulfan (3)  ·  Cyclophosphamide (3)  ·  Doxorubicin (3)  ·  Irinotecan (3)  ·  Magnetic Resonance Spectroscopy (3)

Sponsors

National Cancer Institute (NCI) (28)  ·  Pediatric Brain Tumor Consortium (8)  ·  Children's Oncology Group (6)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  National Institutes of Health Clinical Center (CC) (3)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3)  ·  City of Hope Medical Center (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  OHSU Knight Cancer Institute (2)  ·  Seattle Children's Hospital (2)  ·  Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (2)  ·  St. Jude Children's Research Hospital (2)  ·  Tango Therapeutics, Inc. (2)  ·  AeRang Kim (1)  ·  Ankit Mangla, MD (1)

Countries

United States (94)  ·  Canada (9)  ·  China (6)  ·  Australia (5)  ·  France (4)  ·  United Kingdom (4)  ·  Denmark (2)  ·  Spain (2)  ·  Austria (1)  ·  Belgium (1)  ·  Germany (1)  ·  Ireland (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Russia (1)

Top investigators

Brigitte C Widemann, M.D. (3)  ·  AeRang Kim, MD, PhD (2)  ·  Elizabeth Fox, MD (2)  ·  Mark W. Kieran, MD, PhD (2)  ·  Susan M. Blaney, MD (2)  ·  Aaron H. Wolfson, MD (1)  ·  Aaron Tward, MD (1)  ·  AeRang Kim, MD (1)  ·  Albiruni Razak, M.D. (1)  ·  Allen R. Chen, MD, PhD, MHS (1)  ·  Amar Gajjar (1)  ·  Ankit Mangla, MD (1)  ·  Anna Pawlowska, MD (1)  ·  Antonio Omuro (1)  ·  Barbara Jean Bambach, MD (1)

Results publications

PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15592836, PMID 15814645, PMID 16234526, PMID 16533779, PMID 16914576, PMID 17634493, PMID 17941066, PMID 18048828, PMID 18281544, PMID 18281546, PMID 19065567, PMID 19075272, PMID 19088049, PMID 19430790, PMID 20044751, PMID 20049936, PMID 20460632, PMID 21115653, PMID 21764821, PMID 22934754, PMID 23382028, PMID 23554030, PMID 23857966, PMID 25858498, PMID 28029918, PMID 30410720, PMID 31401903, PMID 32089640, PMID 32187457, PMID 33641042, PMID 34321280, PMID 34331515, PMID 35467749, PMID 36375115, PMID 36884302, PMID 37115514, PMID 37400844, PMID 38869947, PMID 39255444, PMID 39756156, PMID 40709016, PMID 41139346, PMID 42394972, PMID 42540436, PMID 9849694

NIH funding

U01CA081457 (9), U01CA097452 (8), P30CA008748 (2), U01CA069856 (2), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA014599 (1), P30CA033572 (1), U10CA180821 (1), UM1CA081457 (1)